Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B.
about
Sporotrichosis: an overview and therapeutic optionsFixed cutaneous sporotrichosis treated with topical amphotericin B in an immune suppressed patient.Effect of Topical Morphine on Cutaneous Leishmaniasis in an Animal Model: A Preliminary ReportEfficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis.
P2860
Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Topical treatment of persisten ...... thanolic lipid amphotericin B.
@en
Topical treatment of persisten ...... thanolic lipid amphotericin B.
@nl
type
label
Topical treatment of persisten ...... thanolic lipid amphotericin B.
@en
Topical treatment of persisten ...... thanolic lipid amphotericin B.
@nl
prefLabel
Topical treatment of persisten ...... thanolic lipid amphotericin B.
@en
Topical treatment of persisten ...... thanolic lipid amphotericin B.
@nl
P2093
P1476
Topical treatment of persisten ...... thanolic lipid amphotericin B.
@en
P2093
Alex Zvulunov
Daniel Vardy
Emanuala Cagnano
Shoshana Frankenburg
Yehezkel Barenholz
P304
P356
10.1097/00006454-200306000-00017
P577
2003-06-01T00:00:00Z